Yazar "Karaalp, A." için listeleme
-
Prevalence of CYP2C19 Polymorphisms in Clopidogrel Treated Turkish Patients: Preliminary Results, 2017
Susleyici, B.; Ciftci, C.; Yurdakul, S.; Cevik, M.; Akdeniz, C.S.; Canbolat, I.P.; Karaalp, A. (Bentham Science Publishers, 2021)Background: Clopidogrel is one of the most frequently prescribed antiplatelet agents to reduce the risk of atherosclerotic symptoms. CYP2C19 enzyme is involved in clopidogrel metabolism, and several genetic variations of ...